EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Circulating MicroRNA-19 and cardiovascular risk reduction in response to weight-loss diets

Qiaochu Xue, Yoriko Heianza, Xiang Li, Xuan Wang, Hao Ma, Jennifer Rood, Kirsten S Dorans, Katherine T Mills, Xiaowen Liu, George A Bray, Frank M Sacks, Lu Qi

Clinical Nutrition · 2024-03 · 43 (3) · 892-899

DOI: 10.1016/j.clnu.2024.02.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Nutrition, 2024-03. Verfasst von Qiaochu Xue und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA. Hauptthemen laut MEDLINE: Circulating MicroRNA, Cardiovascular Diseases, MicroRNAs, Sleep Wake Disorders. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, FIC NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: MicroRNA-19 (miR-19) plays a critical role in cardiac development and cardiovascular disease (CVD). We examined whether change in circulating miR-19 was associated with change in CVD risk during weight loss. METHODS: This study included 509 participants with overweight or obesity from the 24-month weight-loss diet intervention study (the POUNDS Lost trial) and with available data on circulating miR-19a-3p and miR-19b-3p at baseline and 6 months. The primary outcome for this analysis was the change in atherosclerotic CVD (ASCVD) risk at 6 and 24 months, which estimates the 10-year probability of hard ASCVD events. Secondary outcomes were the changes in ASCVD risk score components. RESULTS: Circulating miR-19a-3p and miR-19b-3p levels significantly decreased during the initial 6-month dietary intervention period (P = 0.008, 0.0004, respectively). We found that a greater decrease in miR-19a-3p or miR-19b-3p was related to a greater reduction in ASCVD risk (β[SE] = 0.33 [0.13], P = 0.01 for miR-19a-3p; β[SE] = 0.3 [0.12], P = 0.017 for miR-19b-3p) over 6 months, independent of concurrent weight loss. Moreover, we found significant interactions between change in miR-19 and sleep disturbance on change in ASCVD risk over 24 months of intervention (P interaction = 0.01 and 0.008 for miR-19a-3p and miR-19b-3p, respectively). Participants with a greater decrease in miR-19 without sleep disturbance had a greater reduction of ASCVD risk than those with slight/moderate/great amounts of sleep disturbance. In addition, change in physical activity significantly modified the associations between change in miR-19 and change in ASCVD risk over 24 months (P interaction = 0.006 and 0.004 for miR-19a-3p and miR-19b-3p, respectively). A greater decrease in miR-19 was significantly associated with a greater reduction in ASCVD risk among participants with an increase in physical activity, while non-significant inverse associations were observed among those without an increase in physical activity. CONCLUSIONS: In conclusion, decreased circulating miR-19 levels during dietary weight-loss interventions were related to a significant reduction in ASCVD risk, and these associations were more evident in people with no sleep disturbance or increase in physical activity. TRIAL REGISTRATION: ClinicalTrials.gov NCT00072995.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Circulating MicroRNACardiovascular DiseasesMicroRNAsSleep Wake DisordersHumansRisk FactorsDiet, ReducingHeart Disease Risk FactorsWeight Loss

Stichwörter der Autor:innen

ASCVD riskCirculating miR-19Physical activitySleep disturbanceWeight loss diet

Substanzen

Circulating MicroRNAMicroRNAsMIRN19A microRNA, human

Autor:innen und Institutionen

  • Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA.
  • Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA, USA.
  • Tulane Center of Biomedical Informatics and Genomics, Deming Department of Medicine, School of Medicine, Tulane University, New Orleans, LA, USA.
  • Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Electronic address…

Förderung

  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • FIC NIH HHS
  • NIGMS NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Heart, Lung, and Blood Institute
  • National Institute of General Medical Sciences
  • Fogarty International Center

Zitieren

APA

Xue, Q., Heianza, Y., Li, X., Wang, X., Ma, H., Rood, J., Dorans, K. S., Mills, K. T., Liu, X., Bray, G. A., Sacks, F. M., & Qi, L. (2024). Circulating MicroRNA-19 and cardiovascular risk reduction in response to weight-loss diets. Clinical Nutrition, 43(3), 892-899. https://doi.org/10.1016/j.clnu.2024.02.015

Vancouver

Xue Q, Heianza Y, Li X, Wang X, Ma H, Rood J, et al. Circulating MicroRNA-19 and cardiovascular risk reduction in response to weight-loss diets. Clinical Nutrition. 2024;43(3):892-899. doi:10.1016/j.clnu.2024.02.015

BibTeX
@article{Xue2024,
  author = {Xue, Qiaochu and Heianza, Yoriko and Li, Xiang and Wang, Xuan and Ma, Hao and Rood, Jennifer and Dorans, Kirsten S and Mills, Katherine T and Liu, Xiaowen and Bray, George A and Sacks, Frank M and Qi, Lu},
  title = {Circulating MicroRNA-19 and cardiovascular risk reduction in response to weight-loss diets},
  journal = {Clinical Nutrition},
  year = {2024},
  volume = {43},
  number = {3},
  pages = {892--899},
  doi = {10.1016/j.clnu.2024.02.015}
}
Kostenlos starten →